Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Belmora Melox Agrura

Last content change checked dailysee data sync status

Active ingredient
Calcium Carbonate 420 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2019
Label revision date
September 8, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Calcium Carbonate 420 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2019
Label revision date
September 8, 2025
Manufacturer
Belmora, LLC
Registration number
M001
NDC root
27854-120
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Belmora Maalox / Melox is a medication designed to provide fast relief from heartburn and stomach discomfort. It contains calcium carbonate (420 mg), which works by neutralizing stomach acid, helping to alleviate symptoms such as acid indigestion, sour stomach, and upset stomach.

This product is available in convenient tamper-evident unit dose packets, making it easy to use whenever you need quick stomach relief. Whether you're dealing with occasional heartburn or discomfort, Belmora Maalox / Melox aims to help you feel better quickly.

Uses

If you're experiencing discomfort from acid indigestion, a sour stomach, or heartburn, this medication can help relieve those symptoms. It is also effective for soothing an upset stomach that comes along with these issues.

You can feel confident using this medication, as there are no known teratogenic effects (which means it doesn't cause birth defects) associated with it. This makes it a safer option for those who may be concerned about such risks.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you can take this medication by chewing 2 tablets every 2 to 3 hours as needed for your symptoms. If your symptoms persist, you may repeat this dosage every hour, but be careful not to exceed a maximum of 19 tablets in a 24-hour period.

For children under 12 years old, it’s important to consult a doctor before giving them this medication. Always follow the guidance provided by your healthcare professional to ensure safe and effective use.

What to Avoid

It's important to use this product safely to avoid potential issues. You should not take the maximum dosage for more than two weeks unless your doctor advises you to do so. Additionally, make sure not to exceed 19 tablets in a 24-hour period. If your symptoms last longer than two weeks, please stop using the product and consult your doctor for further guidance.

Side Effects

It's important to be aware of potential side effects when using this medication. You should consult with your doctor or pharmacist before starting if you are taking any prescription drugs, as antacids can interact with them. Additionally, if you have kidney disease, it's crucial to discuss this with your healthcare provider.

While specific adverse reactions are not detailed here, being informed about possible interactions and health conditions that may affect your use of this medication is essential for your safety. Always prioritize open communication with your healthcare team regarding any concerns you may have.

Warnings and Precautions

It's important to be cautious when using this product. You should not take the maximum dosage for more than two weeks unless your doctor advises you to do so.

If your symptoms last longer than two weeks, please stop using the product and consult your doctor for further guidance. Always prioritize your health and seek professional advice when needed.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, contact your local emergency services or go to the nearest hospital. Having the medication packaging or information on hand can help medical professionals provide the best care. Always remember that when it comes to medications, it's better to be safe and get help if you have any concerns.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is under 12 years old, it's important to consult a doctor before giving them this medication. For those aged 12 and older, you can help manage symptoms by having them chew 2 tablets every 2 to 3 hours as needed. If symptoms persist, they can repeat this hourly, but make sure they do not take more than 19 tablets in a 24-hour period. Always follow these guidelines to ensure safe use.

Geriatric Use

If you are an older adult or caring for one, it's important to consult with a doctor or pharmacist before using this medication, especially if there is a history of kidney disease. Kidney disease can affect how your body processes medications, so getting professional advice ensures safety and effectiveness. Always prioritize open communication with healthcare providers to address any concerns you may have.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Regular monitoring of your kidney function tests is essential to ensure your safety and the effectiveness of your treatment. If your creatinine clearance (a measure of how well your kidneys are filtering waste) is less than 30 mL/min, you may require a lower dose of your medication. Additionally, if you have severe renal impairment, special care should be taken regarding your treatment plan. Always consult with your healthcare provider to ensure that your medication is appropriate for your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, and your healthcare team is there to support you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any tests you might be undergoing. This way, you can avoid any potential issues and receive the best care possible.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature, ideally between 59-86ºF (15-30ºC), in a dry place. It's important to keep the product in its tamper-evident sealed packets, which help ensure that it has not been compromised. If you notice any opened or torn packets, do not use them, as this could affect the product's safety and effectiveness. Always handle the packets with care to maintain their integrity.

Additional Information

No further information is available.

FAQ

What is Belmora Maalox / Melox used for?

Belmora Maalox / Melox is used to relieve acid indigestion, sour stomach, heartburn, and upset stomach associated with these symptoms.

What is the recommended dosage for adults and children 12 years and older?

You should chew 2 tablets every 2-3 hours or as symptoms occur, but do not exceed 19 tablets in a 24-hour period.

What should I do if my symptoms persist?

If your symptoms persist for more than two weeks, you should stop using this product and see a doctor.

Are there any contraindications for using Belmora Maalox / Melox?

No specific contraindications are mentioned for this product.

Can I use Belmora Maalox / Melox if I have kidney disease?

You should ask a doctor or pharmacist before use if you have kidney disease, as renal impairment may necessitate dosage adjustments.

Is it safe to use Belmora Maalox / Melox during pregnancy or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before use.

How should I store Belmora Maalox / Melox?

Store the product at room temperature between 59-86ºF (15-30ºC) in a dry place, and do not use any opened or torn packets.

What are the active ingredients in Belmora Maalox / Melox?

Belmora Maalox / Melox contains Calcium Carbonate 420mg as its active ingredient.

Packaging Info

Below are the non-prescription pack sizes of Belmora Melox Agrura (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Belmora Melox Agrura.
Details

Drug Information (PDF)

This file contains official product information for Belmora Melox Agrura, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Calcium Carbonate is presented in a dosage form containing 420 mg of Calcium Carbonate per unit. The chemical name is Calcium Carbonate, and it is represented by the empirical formula CaCO3.

Uses and Indications

This drug is indicated for the relief of acid indigestion, sour stomach, heartburn, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to chew 2 tablets every 2 to 3 hours as needed for symptom relief. If symptoms persist, the tablets may be repeated hourly, but the total dosage must not exceed 19 tablets within a 24-hour period.

For children under 12 years of age, it is recommended to consult a physician for appropriate dosing guidance.

Contraindications

The product should not be used at the maximum dosage for more than 2 weeks unless advised and supervised by a healthcare professional. Additionally, the intake should not exceed 19 tablets within a 24-hour period. If symptoms persist beyond two weeks, discontinuation of the product is recommended, and a consultation with a healthcare provider is advised.

Warnings and Precautions

The use of this product necessitates careful consideration of the following warnings and precautions to ensure patient safety and efficacy.

Warnings It is imperative to adhere to the specified dosage guidelines to mitigate potential risks associated with misuse.

General Precautions Healthcare professionals should advise patients against using the maximum dosage of this product for longer than two weeks unless directed and monitored by a physician. This precaution is essential to prevent adverse effects that may arise from prolonged high-dose usage.

Monitoring Parameters Currently, there are no specific laboratory tests recommended for monitoring the use of this product. However, healthcare providers should remain vigilant for any signs of adverse reactions or complications.

Patient Instructions Patients are advised to discontinue use and consult their healthcare provider if symptoms persist beyond two weeks. This recommendation is crucial for ensuring that any underlying conditions are appropriately addressed.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. It is important to consult a healthcare professional, such as a doctor or pharmacist, prior to use if they are currently taking a prescription drug, as antacids may interact with certain medications. Additionally, individuals with kidney disease should seek medical advice before using this product, as it may pose specific risks in this population.

While specific adverse reactions were not detailed in the provided information, the importance of monitoring for interactions and contraindications is emphasized. Patients are encouraged to report any unexpected symptoms or reactions to their healthcare provider to ensure safe and effective use of the medication.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Belmora Melox Agrura (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Belmora Melox Agrura.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is to chew 2 tablets every 2-3 hours as needed for symptom relief, with the option to repeat hourly if necessary. It is important not to exceed a total of 19 tablets within a 24-hour period.

Geriatric Use

Elderly patients should consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication, particularly if they have a history of kidney disease. This precaution is essential to ensure the safe and effective use of the medication, as renal function may be compromised in geriatric patients, potentially affecting drug metabolism and excretion. Monitoring and appropriate dose adjustments may be necessary based on individual renal function and overall health status.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure appropriate dosing and minimize the risk of adverse effects. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose may be required. Special consideration should be given to patients with severe renal impairment to ensure their safety and the efficacy of treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with any medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

Management of an overdose typically involves supportive care, which may include the following steps:

  1. Assessment: Conduct a thorough evaluation of the patient's clinical status, including vital signs and level of consciousness.

  2. Supportive Care: Provide symptomatic treatment as necessary, which may involve intravenous fluids, oxygen supplementation, or other interventions based on the patient's needs.

  3. Consultation: Engage with a poison control center or toxicology specialist for guidance on specific antidotes or additional management strategies, if applicable.

It is crucial for healthcare professionals to document the incident thoroughly and report any adverse events to the appropriate regulatory authorities. Continuous education on the signs of overdose and the importance of prompt intervention can significantly improve patient outcomes in such scenarios.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children to prevent accidental ingestion. It is important to inform patients that they should not use the maximum dosage of this product for more than two weeks unless directed by a healthcare professional.

Patients should be instructed not to exceed 19 tablets within a 24-hour period. If symptoms persist for more than two weeks, they should discontinue use and consult a doctor.

Additionally, healthcare providers should recommend that patients consult with a doctor or pharmacist prior to using this product if they are currently taking any prescription medications, as antacids may interact with certain drugs. Patients with a history of kidney disease should also be advised to seek medical guidance before using this product.

Storage and Handling

The product is supplied in tamper-evident sealed packets, ensuring the integrity and safety of the contents. It is essential to store the packets at room temperature, specifically within the range of 59-86ºF (15-30ºC), in a dry place to maintain optimal quality.

Healthcare professionals are advised to refrain from using any packets that are opened or torn, as this may compromise the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Belmora Melox Agrura, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Belmora Melox Agrura, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.